Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$88.02 - $127.79 $7.06 Million - $10.3 Million
-80,230 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$122.75 - $162.68 $8.36 Million - $11.1 Million
68,095 Added 561.15%
80,230 $10.3 Million
Q2 2021

Aug 13, 2021

BUY
$105.76 - $154.96 $1.28 Million - $1.88 Million
12,135 New
12,135 $1.85 Million
Q3 2020

Nov 12, 2020

SELL
$45.65 - $61.81 $3.41 Million - $4.62 Million
-74,741 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$29.15 - $61.54 $2.18 Million - $4.6 Million
74,741 New
74,741 $4.6 Million
Q4 2018

Feb 14, 2019

SELL
$28.91 - $50.0 $1.28 Million - $2.22 Million
-44,325 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$30.85 - $50.65 $1.84 Million - $3.02 Million
-59,605 Reduced 57.35%
44,325 $2.13 Million
Q2 2018

Aug 14, 2018

BUY
$13.95 - $32.65 $1.45 Million - $3.39 Million
103,930 New
103,930 $3.22 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.4B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.